MAR-TERIFLUNOMIDE

marcan pharmaceuticals inc🇨🇦 Health Canada

Approval Id: db2bd9cfefead7aa
Drug Approval Canada Name: MAR-TERIFLUNOMIDE
Product Name: MAR-TERIFLUNOMIDE
Status: Marketed
Status Date: 2022-05-18
Original Market Date: 2022-05-18
Din: 02500469
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 90:04.20
Atc Original: L04AK02 TERIFLUNOMIDE
Atc Name: l 04 ak 02
Aig Number: 0154970001
Company Name: marcan pharmaceuticals inc
Company Address: 2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2

TERIFLUNOMIDE

14 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

db2bd9cfefead7aa

Type

Standard